Strong Origination Momentum
Closed 32 new loans for $941 million of total commitments since restarting originations (end of 2024); Q4 2025 closed 13 loans totaling $416 million (largest funding quarter since restart). Loan portfolio grew $315 million to $2.7 billion as of 12/31/2025, a 13% increase from Q3.
Fourth Managed CLO Execution
Closed a $955 million managed CLO featuring a $98 million ramp and a 2.5-year reinvestment period; transaction had strong investor demand with 19 investors participating, increasing lending capacity and flexibility.
Adjusted Distributable Earnings and Full-Year Coverage
Adjusted DE for Q4 2025 was $19.3 million ($0.15/share). For full year 2025 adjusted DE was $83.6 million ($0.64/share), representing a ~7.4% return on undepreciated shareholders' average equity. Full-year dividend of $0.64/share was fully covered on time.
Improved Reserve Position
General CECL provision decreased to $88 million (315 basis points on total loan commitments) from $127 million (517 basis points) in Q3 — a decline of 202 basis points (~39% reduction), indicating reserve improvement versus the prior quarter.
Healthy Liquidity and Capital Availability
Total liquidity approximately $168 million including $98 million unrestricted cash (with ~$64 million expected from CLO unwind) plus $70 million available on credit facility, supporting origination and portfolio activity.
Share Repurchases and Book Value Support
Repurchased ~1.1 million shares at an average price of $5.39 in Q4, producing approximately $0.03 of book value accretion and management signaling belief the stock remains materially undervalued.
Clear 2026 Growth and Execution Plan
Management priorities: grow loan book to ~$3.5 billion in 2026, resolve remaining watch list and monetize majority of REO (notably San Jose Hotel), execute a fifth CLO in H2 2026, and reestablish positive dividend coverage by year-end.